scholarly journals Eurosurveillance moves on…

2008 ◽  
Vol 13 (1) ◽  
pp. 1-2
Author(s):  
K Ekdahl ◽  
I Steffens

From this issue of Eurosurveillance, the two previous electronic releases (weekly and monthly) of the journal have been merged into one. The new Eurosurveillance is published every Thursday, with rapid updates on major public health events and news items alongside longer scientific articles and reviews. At the same time we are updating our editorial policy (http://www.eurosurveillance.org/editorial_policy/index.asp) and reviewing the types of articles (http://www.eurosurveillance.org/authors/index.asp) to better reflect our commitment to covering all aspects of epidemiology, prevention and control of communicable diseases from a European perspective.

2005 ◽  
Vol 10 (48) ◽  
Author(s):  
G Zagrebneviene ◽  
V Jasulaitiene ◽  
B Morkunas ◽  
S Tarbunas ◽  
J Ladygaite

On 7 October 2004, the Vilnius Public Health Centre reported five shigellosis cases in Vilnius, all typed as Shigellosis sonnei, to the National Centre for Communicable Diseases Prevention and Control. Preliminary patient data suggested that the infections were all acquired from unpasteurised milk curds bought from two markets in Vilnius.


2004 ◽  
Vol 8 (25) ◽  
Author(s):  
I Klavs ◽  
A Hocevar-Grom ◽  
M Socan ◽  
M Grgic-Vitek ◽  
L Pahor ◽  
...  

National communicable disease surveillance, prevention and control in Slovenia is coordinated by the Communicable Diseases Centre of the Institute of Public Health of the Republic of Slovenia


2004 ◽  
Vol 8 (25) ◽  
Author(s):  
A Bormane ◽  
I Lucenko ◽  
J Perevoščikovs

The Latvian public health service dates back to 1947. The Sanitary Epidemiological Service, created in Soviet times, provided two main functions – assessment of health risk factors, including surveillance of communicable diseases, and inspection.


2007 ◽  
Vol 12 (50) ◽  
Author(s):  
R Strauss ◽  
R Muchl ◽  
S Metz-Gercek ◽  
M Sagl ◽  
F Allerberger ◽  
...  

The first epidemiological report on communicable diseases in Europe published by the European Centre for Disease Prevention and Control (ECDC) identified antibiotic resistance and nosocomial infections as one of the major threats in public health in the future.


2020 ◽  
Author(s):  
Hui Cheng ◽  
Meng Luo ◽  
Shaohua Li

Abstract Objective: Based on the Prevention and Control of COVID-19, this paper points out the shortcomings of China's current medical insurance system, and puts forward the concept of establishing emergency medical insurance system.Methods: This paper analyzes the characteristics of the modern epidemic and its special requirements for medical insurance. Putting forward the idea of mechanism construction.Results:The operation of China's national medical insurance system is mainly operated by the insured, the government, medical institutions and medical institutions. However, the rapid spread of the epidemic has caused great disasters to the society. In the face of major public health events, medical insurance should have four characteristics: the "normalization" of the emergency medical insurance system, the fairness of guarantees, the public quality of treatment and positive externalities. China should establish an emergency system in line with these four characteristics from the four parties. Therefore, this paper analyzes the characteristics of modern epidemic risk, its development process and the requirements for the insurance industry in combination with the situation of China's response to dealing with COVID-19, and puts forward that China should further improve the universal medical insurance system and establish an emergency medical security system to better deal with all kinds of sudden public health events, which will still happen in the future.Conclusions:China's national medical insurance system should not be limited to meet people's conventional medical needs. When public health emergencies occur, it is also necessary to establish a sound medical insurance system to operate.The establishment of emergency medical security system is one of the important development directions of our country in the future.


2021 ◽  
Vol 45 (9) ◽  
Author(s):  
Jiancheng Dong ◽  
Huiqun Wu ◽  
Dong Zhou ◽  
Kaixiang Li ◽  
Yuanpeng Zhang ◽  
...  

AbstractCOVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), spread rapidly and affected most of the world since its outbreak in Wuhan, China, which presents a major challenge to the emergency response mechanism for sudden public health events and epidemic prevention and control in all countries. In the face of the severe situation of epidemic prevention and control and the arduous task of social management, the tremendous power of science and technology in prevention and control has emerged. The new generation of information technology, represented by big data and artificial intelligence (AI) technology, has been widely used in the prevention, diagnosis, treatment and management of COVID-19 as an important basic support. Although the technology has developed, there are still challenges with respect to epidemic surveillance, accurate prevention and control, effective diagnosis and treatment, and timely judgement. The prevention and control of sudden infectious diseases usually depend on the control of infection sources, interruption of transmission channels and vaccine development. Big data and AI are effective technologies to identify the source of infection and have an irreplaceable role in distinguishing close contacts and suspicious populations. Advanced computational analysis is beneficial to accelerate the speed of vaccine research and development and to improve the quality of vaccines. AI provides support in automatically processing relevant data from medical images and clinical features, tests and examination findings; predicting disease progression and prognosis; and even recommending treatment plans and strategies. This paper reviews the application of big data and AI in the COVID-19 prevention, diagnosis, treatment and management decisions in China to explain how to apply big data and AI technology to address the common problems in the COVID-19 pandemic. Although the findings regarding the application of big data and AI technologies in sudden public health events lack validation of repeatability and universality, current studies in China have shown that the application of big data and AI is feasible in response to the COVID-19 pandemic. These studies concluded that the application of big data and AI technology can contribute to prevention, diagnosis, treatment and management decision making regarding sudden public health events in the future.


2004 ◽  
Vol 8 (19) ◽  
Author(s):  
Olga Poyiadji-Kalakouta

The Medical and Public Health Services of the Ministry of Health of Cyprus have recently developed a new Network for the Surveillance and Control of Communicable Diseases


2021 ◽  
Author(s):  
Natalia Oli ◽  
Pranil MS Pradhan ◽  
Reshu A Sagtani ◽  
Archana Shrestha ◽  
Lindsay M. Jaacks ◽  
...  

Abstract BackgroundDespite a high burden, there is limited training available in non-communicable disease research in Nepal. In order to understand research capacity gap in non-communicable diseases in the country, we conducted a needs assessment. We aimed to assess existing research training capacity in academic health institutions of Nepal for the prevention and control of non-communicable diseases, identify gaps in research training in these institutions, and explore the feasibility of developing research training program in Nepal targeting non-communicable diseases and their risk factors. MethodsWe did qualitative and quantitative research and reviewed academic institution curricula review and scientific literature. We conducted 14 Focus Group Discussions with bachelor and Masters level students of public health and community medicine; 25 In-depth Interviews with department heads and faculties, and government stakeholders. We surveyed medical and public health students on their research knowledge and skills development. Further, we reviewed university curricula of bachelors in medicine and public health Masters in community medicine and public health. We also reviewed non-communicable disease related scientific articles authored by Nepali researchers. ResultsWe found that the research methodology component was addressed differently across academic programs. One-third (33.7%) of students expressed lack of skills for analysis and interpretation of data. They felt that there is a wide scope and career-interest in non-communicable diseases research in Nepal. However, specific objectives in the curriculum and practical aspects regarding non-communicable diseases were lacking. Most of the non-communicable diseases research in Nepal are prevalence studies. Most of the studies did not have any financial support. Lack of funding, conflicting priorities with curative services, and inadequate training for advanced research tools were reported as major barriers. Likewise, availability of trained human resources and international funding for non-communicable diseases research were perceived facilitators.ConclusionsNepal must strengthen the whole spectrum of research capacity: epidemiological skills, research management, and fund generation. University curricula should match up with the disease burden and must emphasize on applied practical research projects. Generation of a critical mass of non-communicable disease researchers must go together with improved funding from the government, non-governmental organizations, and external funding organizations.


Author(s):  
Modupe Coker ◽  
Morenike O. Folayan ◽  
Ian C. Michelow ◽  
Regina E. Oladokun ◽  
Nguavese Torbunde ◽  
...  

Abstract Zero to 19 year-old children in sub-Saharan Africa bear a disproportionate proportion of the global burden of communicable and non-communicable diseases. Significant public health gains have been made in the fight against these diseases, however, factors such as underequipped health systems, disease outbreaks, conflict, and political instability continue to challenge prevention and control. The novel coronavirus disease (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) introduces new challenges to public health programs in sub-Saharan Africa. Of particular concern are programs targeting major conditions among children, such as undernutrition, vaccine-preventable pneumonia and diarrhea, malaria, tuberculosis, HIV, and sickle cell disease. This article focuses on the impact of the COVID-19 pandemic on child health in sub-Saharan Africa. We review the epidemiology of major pediatric diseases and, referencing modeling projections, discuss the short- and long-term impact of the pandemic on major disease control. We deliberate on potential complications of SARS-CoV-2 co-infections/co-morbidities and identify critical social and ethical issues. Furthermore, we highlight the paucity of COVID-19 data and clinical trials in this region and the lack of child participants in ongoing studies. Lastly, approaches and interventions to mitigate the pandemic’s impact on child health outcomes are discussed. Impact Children in sub-Saharan Africa bear a disproportionate burden of communicable and non-communicable diseases globally; this remains true even as the COVID-19 pandemic persists. Amidst the fast-expanding COVID-19 literature, there is little comprehensive coverage of the pandemic’s indirect impact on child health in sub-Saharan Africa. This article comprehensively outlines the threat that the pandemic poses to major disease prevention and control for children in sub-Saharan Africa. It discusses the potential impact of SARS-CoV-2 co-infections/co-morbidities, highlights research gaps, and advocates for data and action to mitigate the ripple effects of the pandemic on this population.


Sign in / Sign up

Export Citation Format

Share Document